Invention Grant
- Patent Title: Use of semaphorin-4D binding molecules for the treatment of Rett syndrome
-
Application No.: US17352574Application Date: 2021-06-21
-
Publication No.: US11597765B2Publication Date: 2023-03-07
- Inventor: Yilin Mao , Wendy Gold , Elizabeth E. Evans , Maurice Zauderer
- Applicant: VACCINEX, INC. , The Sydney Children's Hospital Network
- Applicant Address: US NY Rochester; AU Westmead
- Assignee: VACCINEX, INC.,The Sydney Children's Hospital Network
- Current Assignee: VACCINEX, INC.,The Sydney Children's Hospital Network
- Current Assignee Address: US NY Rochester; AU Westmead
- Agency: KDB Firm PLLC
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/28 ; A61P25/00
Abstract:
Provided herein are methods for alleviating symptoms in a subject having Rett syndrome, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D).
Public/Granted literature
- US20210403559A1 USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SYNDROME Public/Granted day:2021-12-30
Information query
